Drug development for TB: an innovative collaboration

A landmark collaboration could see the development of the first new-action tuberculosis drug in 40 years.  Global Alliance for TB Drug Development (TB Alliance), a not-for-profit, product development partnership, and Tibotec, a Johnson & Johnson company, have joined forces to focus on the development of the new experimental drug TMC207.
Forbes reports that if the drug [...]

WHO Releases new Tuberculosis Report

The World Health Organization released its’ thirteenth report on Tuberculosis control this week, which provides information and statistics related to the numbers of cases and numbers of deaths due to TB in 196 countries.   The report stresses the link between HIV and TB, suggesting that roughly 25% of people who died from TB in 2007 were [...]

Canadian researchers begin first phase of human trials in new TB vaccine; 11 other TB vaccines in various stages of research at facilities around the world

Tuberculosis, the world’s second deadliest infectious disease could finally meet its match in a new vaccine developed by researchers at McMaster University.  The new vaccine is at least five years away from broad use, if it can be shown to be safe, effective and practical to make and distribute — and if another team doesn’t [...]